Trends and Outcomes of Endoscopic Versus External Dacryocystorhinostomy: A 20-year Retrospective Multi-Institutional Analysis

医学 泪囊鼻腔吻合术 回顾性队列研究 外科 普通外科
作者
Natalia Davila,Samantha A. McLaughlin,Tejus Pradeep,Brian Wong,Wendy W. Lee
出处
期刊:Ophthalmic Plastic and Reconstructive Surgery [Lippincott Williams & Wilkins]
被引量:1
标识
DOI:10.1097/iop.0000000000003049
摘要

Purpose: To evaluate 20-year multi-institutional trends in endoscopic dacryocystorhinostomy (EN-DCR) versus external dacryocystorhinostomy (EX-DCR) for acquired nasolacrimal duct obstruction, including comparative long-term revision rates. Methods: A retrospective cohort study was performed using the TriNetX federated research network. Annual surgical volumes and revision rates at 1, 10, and 20 years were analyzed for patients undergoing EN-DCR or EX-DCR. Propensity-score matching controlled for demographic and clinical characteristics. Joinpoint regression identified trends and significant shifts in procedural rates over time, expressed as annual percent change (APC) for specific intervals and average APC overall. Results: A total of 14,135 DCR procedures (9,948 EX-DCR, 4,187 EN-DCR) were performed on 12,623 patients. Over the study period, EX-DCR decreased from 87.1% to 60.0% (average APC, –1.9%; p < 0.05), with a greater decline noted after 2018 (APC, –3.9%; p < 0.01). Conversely, EN-DCR increased from 12.9% to 40.1% (overall average APC, +4.9%; p = 0.08), showing significant growth after 2012 (APC, +4.4%; p < 0.01). Surgical revision rates were similar at 1 (EX-DCR 9.0% vs. EN-DCR 8.6%, risk ratios = 1.04, p = 0.61), 10 (EX-DCR 14.5% vs. EN-DCR 13.6%, risk ratios = 1.06, p = 0.31), and 20 years (EX-DCR 14.7% vs. EN-DCR 13.7%, risk ratios = 1.07, p = 0.25). Overall success rates, defined as no surgical revision, were between 85.3% and 91.4% for both approaches. Conclusion: Over the past 20 years, endoscopic DCR has gained popularity, with steadily increasing use and comparable revision rates to external DCR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
耶斯发布了新的文献求助10
1秒前
上官若男应助fortune采纳,获得10
1秒前
qiuqiu发布了新的文献求助10
1秒前
大个应助猫小乐C采纳,获得10
3秒前
小马甲应助耍酷谷云采纳,获得10
3秒前
瑞芬太尼完成签到,获得积分10
4秒前
Jasper应助研友_楼灵煌采纳,获得20
4秒前
bajuwei完成签到,获得积分10
4秒前
5秒前
Yohi发布了新的文献求助10
5秒前
qsmei2020发布了新的文献求助10
6秒前
强强强强去完成签到,获得积分10
6秒前
7秒前
Furina应助猫小乐C采纳,获得20
7秒前
在水一方应助摆烂昊采纳,获得10
7秒前
8秒前
8秒前
研友_VZG7GZ应助liewudb采纳,获得10
8秒前
欢呼的未来完成签到 ,获得积分10
9秒前
CYN完成签到,获得积分10
9秒前
bajuwei发布了新的文献求助10
9秒前
耶斯完成签到,获得积分10
10秒前
10秒前
在水一方应助yueshao采纳,获得10
10秒前
希望天下0贩的0应助yueshao采纳,获得10
10秒前
10秒前
10秒前
真实的蹇完成签到,获得积分10
10秒前
第一霸发布了新的文献求助10
11秒前
wxl完成签到 ,获得积分10
11秒前
施宛儿完成签到 ,获得积分10
11秒前
ycy完成签到 ,获得积分10
12秒前
lllcccc发布了新的文献求助10
12秒前
小耗子完成签到,获得积分10
12秒前
界徐盛女粉丝完成签到,获得积分10
12秒前
lllllll完成签到,获得积分10
12秒前
麦客完成签到,获得积分10
12秒前
12秒前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
The Immune System (Fifth Edition) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6557942
求助须知:如何正确求助?哪些是违规求助? 8341517
关于积分的说明 17871944
捐赠科研通 5677241
什么是DOI,文献DOI怎么找? 2941019
邀请新用户注册赠送积分活动 1916859
关于科研通互助平台的介绍 1788037